Revenue
€952,307
2024 · latest filed year
Employees
12
2026-06
Average wage
€4,675
monthly, before tax
Tax arrears
No recorded arrears
No data
Company overview
AI researchA source-linked overview of the company's activities based on public information.
Optimapharm Lithuania UAB is the Lithuanian entity listed in Optimapharm's current corporate register. The Optimapharm group offers Phase I-IV clinical trial, functional service provision and real-world research solutions to biotechnology and pharmaceutical sponsors.
Primary activity
Products and services
Sources
Researched: 27 August 2026 · Confidence: High · This overview was prepared by AI. Verify important claims with the linked primary sources.
Registry information
- Company code
- 304042868
- Legal form
- Private Limited Liability Company
- Status
- No legal proceedings
- Registered
- 14 May 2015
- Municipality
- —
- Registered office
- Kaunas, R. Kalantos g. 161, LT-52315
- Office registered since
- 14 May 2015
- Office data updated
- 7 August 2026
Insolvency proceedings
Official AVNT company bankruptcy and restructuring data. Administrator identities and contact details are not shown.
- Active proceeding
- No
- Proceedings on record
- 0
VAT information
- VAT registered
- Yes
- VAT number
- LT100009575410
- VAT registered on
- 1 September 2015
- Of which overdue
- €0
Primary activity
- EVRK code
- 721900
- Primary activity
- Not provided
- Employees
- 12 (2026-06)
- Average wage
- €4,675
Participant structure
Only aggregate participant counts are published, without personal data.
- Total participants
- 1
- Lithuanian natural persons
- 0
- Lithuanian legal persons
- 0
- Foreign natural persons
- 0
- Foreign legal persons
- 1
- Has foreign participants
- Yes
Online presence
A website and its published information are shown only after its link to the legal entity is verified.
No verified company website has been found yet.
Tax and public procurement
A summary of taxes paid from VMI and contracts published by the Public Procurement Office.
- Taxes paid year to date
- €66,120
- Reporting period
- June 2026
- Public contracts
- 0
- Total contract value
- —
- Latest contract
- —
Financials
Key figures from the company's filed annual financial statements.
| Year | Revenue | Profit before tax | Net profit | Total assets | Equity |
|---|---|---|---|---|---|
| 2024 | €952,307 | €60,287 | €50,440 | €365,496 | €315,500 |
| 2023 | €1,020,985 | €56,423 | €36,814 | €507,955 | €265,060 |
| 2022 | €743,587 | €28,459 | €23,508 | €329,722 | €228,246 |
| 2021 | €819,964 | €31,572 | €25,841 | €276,705 | €204,738 |
| 2020 | €875,720 | €36,654 | €29,174 | €280,491 | €178,897 |
| 2019 | €1,042,201 | €40,116 | €26,451 | €245,147 | €149,723 |
Filed: 4 June 2025
Similar companies
Active companies in the same sector, ranked by latest revenue.
Scientific research and development
- UAB Biotechnologinės farmacijos centras "Biotechpharma"€74,035,286
- UAB "Biosantara"€74,035,286
- Nacionalinis vėžio institutas€46,373,001
- Baltic Champs, UAB€31,051,154
- UAB "Lietuvos cukraus fabrikas"€26,039,332
- Uždaroji akcinė bendrovė "Biomapas"€22,744,500
- MB "Matučiukai"€20,210,326
- UAB "LT Biotech"€14,452,601
Sources: State Enterprise Centre of Registers, VMI, Sodra and the Public Procurement Office. Website ownership is checked against .lt domain data and legal-entity details published on the website. Open data is licensed under CC BY 4.0.